readthroughSign in
CompanySLNSLNCFNasdaq, OTCLondon

Silence Therapeutics plc

Silence Therapeutics develops siRNA therapies using its mRNAi GOLD platform to target genes causing disease.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story